2024/09/18 08:03:36 | |
---|---|
Price | |
14.595 EUR | |
Difference | 0.00% (0.00) |
ISIN | US0042251084 |
Symbol | ACAD |
Exchange | Munich |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 2,425 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 14.70 EUR (400) |
Ask (Ask size) | 14.765 EUR (400) |
Open | 14.595 EUR |
High | 14.595 EUR |
Low | 14.595 EUR |
Close (prev. day) | 14.595 EUR |
VWAP | 25.40 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/18 08:03:36 | |
---|---|
Price | |
14.595 EUR | |
Difference | 0.00% (0.00) |
ISIN | US0042251084 |
Symbol | ACAD |
Exchange | Munich |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 2,425 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 14.70 EUR (400) |
Ask (Ask size) | 14.765 EUR (400) |
Open | 14.595 EUR |
High | 14.595 EUR |
Low | 14.595 EUR |
Close (prev. day) | 14.595 EUR |
VWAP | 25.40 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -15.64% | -40.18% | +7.20% |
Perf (abs.) | -2.71 | -9.81 | +0.98 |
Beta | - | - | - |
Volatility | 33.38 | 45.62 | 54.33 |
Ø price 5 days | Ø volume 5 days (pcs.) | 14.437 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 14.416 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 14.910 EUR (0) |
Ø price 250 days | Ø volume 250 days (pcs.) | 18.945 EUR (0) |
YTD High | date | 28.200 EUR (2024/01/02) |
YTD Low | date | 13.530 EUR (2024/05/30) |
52 Weeks High | date | 28.200 EUR (2023/12/28) |
52 Weeks Low | date | 13.530 EUR (2024/05/30) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Berlin | 2024/09/18 | 08:08 | 14.525 EUR | 0.00 | 1 |
Duesseldorf | 2024/09/18 | 19:31 | 14.69 EUR | 0.00 | 5 |
Frankfurt | 2024/09/18 | 08:04 | 14.52 EUR | 0.00 | 1 |
London Stock Exchange | 2024/09/17 | 15:33 | 16.29 USD | 0.00 | 2 |
Munich | 2024/09/18 | 08:03 | 14.595 EUR | 0.00 | 1 |
Nasdaq | 2024/09/18 | 19:37 | 16.385 USD | 4.49 | 6,514 |
Stuttgart | 2024/09/18 | 18:28 | 14.715 EUR | 0.00 | 3 |
Tradegate | 2024/09/17 | 22:02 | 14.645 EUR | 0.00 | 1 |
ACADIA PHARMACEUTICALS INC. |
- - |
Sorrento Valley Blvd. 3911 92121 San Diego, CA |
Telefon: +1 (858) 558-2871 |
Fax: +1 (858) 558-2872 |
E-mail: info@acadia-pharm.com |
- |
Stephen Biggar | Chairman of Board of Directors |
Adora Ndu | Member of Board of Directors |
Edmund Harrigan | Member of Board of Directors |
Elizabeth Garofalo | Member of Board of Directors |
Daniel Soland | Member of Board of Directors |
James Daly | Member of Board of Directors |
Julian Baker | Member of Board of Directors |
Laura Brege | Member of Board of Directors |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer